Emcure Pharmaceuticals Share Price
Know More₹1,515.95 32.50 (2.19%)
6-Feb-2026₹1,515.70 33.40 (2.25%)
6-Feb-2026BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 06-Feb-2026 | 05:30 AM IST
| Market Cap (₹ Cr.) | 28,738 |
Traded Value (₹ Cr) | 0.79 |
Volume (Shares) | 5,211 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,585.50 |
52-Week High Date | 19-Jan-2026 |
52-Week Low (₹) | 890.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,585.50 |
All Time High Date | 19-Jan-2026 |
All Time Low (₹) | 890.00 |
All Time Low Date | 07-Apr-2025 |
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd News
Emcure Pharma Announcement
Appointment of Ms. Amruta Jana Yangalwar as Company Secretary and Compliance Officer of the Company.
Emcure Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr.) | 28,733 |
| EPS - TTM (₹) [C] | 47.20 |
| P/E Ratio (X) [C] | 32.11 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.20 |
| Book Value Share (₹) [C] | 250.17 |
| P/B Ratio (₹) [C] | 6.06 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Healthcare Fund (IDCW) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund (G) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund - Direct (G) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund - Direct (IDCW) | 10.98 | 75,000 | 1.04 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,461.10 1,520.00 |
| Week Low/High (₹) | 1,422.20 1,554.00 |
| Month Low/High (₹) | 1,410.00 1,586.00 |
| Year Low/High (₹) | 889.00 1,586.00 |
| All time Low/High (₹) | 890.00 1,586.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 3.50% | 3.55% | 1.59% | 1.47% |
| 1 Month | -0.71% | -0.80% | -1.74% | -1.85% |
| 3 Month | 14.36% | 14.42% | 0.15% | 0.38% |
| 6 Month | 6.65% | 6.57% | 3.77% | 4.56% |
| 1 Year | 17.86% | 17.93% | 7.07% | 8.86% |
| 3 Year | - | - | 38.13% | 44.63% |
Company Info
Company Information
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA
Chairman (Non-Executive) : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
FAQs about Emcure Pharmaceuticals Ltd
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,515.95 at close on 6th Feb 2026. Emcure Pharmaceuticals Ltd share price was up by 2.19% over the previous closing price of Rs 1,483.45. Emcure Pharmaceuticals Ltd share price trend:
- Last 1 Month: Emcure Pharmaceuticals Ltd share price moved down by 0.71% on BSE.
- Last 3 Months: Emcure Pharmaceuticals Ltd share price moved up by 14.36% on BSE.
- Last 12 Months: Emcure Pharmaceuticals Ltd share price moved up by 17.86% on BSE.
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 32.11
- Price to book value ratio is 6.06
- Dividend yield of 0.20
- The EPS (trailing 12 months) of the Emcure Pharmaceuticals Ltd stock is Rs 47.20
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 28,738 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,585.50 and 52-week low share price is Rs 890.00.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 231.37 crore on a total income of Rs 2,365.33 crore for the quarter ended 2025. For the year ended 2025, Emcure Pharmaceuticals Ltd had posted a profit of Rs 707.47 crore on a total income of Rs 7,896.00 crore.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt, Astrazeneca Phar, Piramal Pharma.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Emcure Pharmaceuticals Ltd has gone down to 77.88 per cent as of Dec 2025 from 77.92 per cent as of Mar 2025.
